Myriad Genetics Newsroom

Myriad Genetics Is Maintained at Underperform by B of A Securities

Dow JonesDec 14 00:26

Myriad Genetics Analyst Ratings

BenzingaDec 14 00:15

BofA Securities Maintains Myriad Genetics(MYGN.US) With Sell Rating, Cuts Target Price to $13

Futu NewsDec 13 21:33

Myriad Genetics Initiated at Neutral by UBS

Dow JonesDec 10 21:02

Cautious Hold: Myriad Genetics Faces Growth Uncertainty Amid Reimbursement Challenges

TipRanksDec 10 18:39

UBS Initiates Myriad Genetics(MYGN.US) With Hold Rating, Announces Target Price $18

Futu NewsDec 10 18:34

Myriad Genetics Analyst Ratings

BenzingaDec 9 20:34

Leerink Partners Downgrades Myriad Genetics(MYGN.US) to Hold Rating, Cuts Target Price to $21

Futu NewsDec 9 19:31

Morgan Stanley Maintains Myriad Genetics(MYGN.US) With Hold Rating, Cuts Target Price to $21

Futu NewsNov 18 17:31

Scotiabank Maintains Myriad Genetics(MYGN.US) With Buy Rating, Cuts Target Price to $24

Futu NewsNov 13 20:35

Myriad Genetics Is Maintained at Neutral by Piper Sandler

Dow JonesNov 11 21:07

Myriad Genetics Analyst Ratings

BenzingaNov 11 20:57

J.P. Morgan Maintains Myriad Genetics(MYGN.US) With Sell Rating, Cuts Target Price to $15

Futu NewsNov 11 20:34

Piper Sandler Maintains Myriad Genetics(MYGN.US) With Hold Rating, Cuts Target Price to $24

Futu NewsNov 11 20:34

Analysts Offer Insights on Healthcare Companies: Myriad Genetics (MYGN) and Jazz Pharmaceuticals (JAZZ)

TipRanksNov 11 20:18

TD Cowen Maintains Myriad Genetics(MYGN.US) With Hold Rating, Maintains Target Price $20

Futu NewsNov 8 21:32

TD Cowen Maintains Myriad Genetics(MYGN.US) With Hold Rating, Cuts Target Price to $20

Futu NewsNov 8 12:32

Cautious Hold Recommendation for Myriad Genetics Amid GeneSight Coverage Challenges and Mixed Revenue Signals

TipRanksNov 8 12:08

TD Cowen Maintains Myriad Genetics(MYGN.US) With Hold Rating, Maintains Target Price $30

Futu NewsNov 4 20:35

TD Cowen Reaffirms Their Hold Rating on Myriad Genetics (MYGN)

TipRanksNov 4 20:27